Concepts (79)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lupus Erythematosus, Systemic | 6 | 2024 | 257 | 4.140 |
Why?
|
| Early Detection of Cancer | 2 | 2024 | 1340 | 0.950 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2024 | 1903 | 0.780 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2023 | 496 | 0.780 |
Why?
|
| Scleroderma, Systemic | 1 | 2022 | 165 | 0.740 |
Why?
|
| Vaginal Smears | 1 | 2021 | 166 | 0.730 |
Why?
|
| Patient Compliance | 1 | 2024 | 676 | 0.680 |
Why?
|
| Hypertension, Pulmonary | 1 | 2023 | 464 | 0.610 |
Why?
|
| Reminder Systems | 1 | 2016 | 70 | 0.520 |
Why?
|
| Death, Sudden | 1 | 2014 | 56 | 0.480 |
Why?
|
| Vital Signs | 1 | 2014 | 24 | 0.470 |
Why?
|
| Terminal Care | 4 | 2016 | 467 | 0.460 |
Why?
|
| Malnutrition | 1 | 2017 | 224 | 0.450 |
Why?
|
| Terminally Ill | 1 | 2014 | 97 | 0.430 |
Why?
|
| Mortality | 1 | 2014 | 347 | 0.410 |
Why?
|
| Physical Examination | 1 | 2014 | 305 | 0.410 |
Why?
|
| Palliative Care | 4 | 2017 | 2178 | 0.390 |
Why?
|
| Medication Adherence | 1 | 2016 | 513 | 0.380 |
Why?
|
| Critical Care | 1 | 2014 | 796 | 0.310 |
Why?
|
| Immunosuppressive Agents | 2 | 2023 | 1432 | 0.270 |
Why?
|
| Cross-Sectional Studies | 3 | 2024 | 4492 | 0.240 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2022 | 7044 | 0.230 |
Why?
|
| Heart Failure | 1 | 2017 | 2330 | 0.220 |
Why?
|
| Incidence | 3 | 2022 | 5824 | 0.220 |
Why?
|
| Rheumatic Diseases | 1 | 2024 | 100 | 0.220 |
Why?
|
| Observational Studies as Topic | 1 | 2023 | 144 | 0.210 |
Why?
|
| Blood Sedimentation | 1 | 2022 | 38 | 0.210 |
Why?
|
| Rheumatology | 1 | 2023 | 138 | 0.200 |
Why?
|
| Longitudinal Studies | 3 | 2023 | 2057 | 0.200 |
Why?
|
| Neoplasms | 5 | 2017 | 15927 | 0.200 |
Why?
|
| Prospective Studies | 4 | 2022 | 13414 | 0.190 |
Why?
|
| Humans | 17 | 2024 | 270740 | 0.190 |
Why?
|
| Consensus | 2 | 2023 | 1106 | 0.180 |
Why?
|
| C-Reactive Protein | 1 | 2022 | 558 | 0.160 |
Why?
|
| Adult | 7 | 2024 | 82040 | 0.150 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 16215 | 0.150 |
Why?
|
| Patient-Centered Care | 1 | 2021 | 318 | 0.150 |
Why?
|
| Aged | 7 | 2024 | 73333 | 0.150 |
Why?
|
| Medicare | 1 | 2022 | 926 | 0.140 |
Why?
|
| Off-Label Use | 1 | 2017 | 48 | 0.140 |
Why?
|
| Female | 9 | 2024 | 148940 | 0.140 |
Why?
|
| Middle Aged | 7 | 2024 | 90352 | 0.130 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2024 | 1235 | 0.130 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2024 | 1302 | 0.130 |
Why?
|
| Retrospective Studies | 3 | 2023 | 39890 | 0.120 |
Why?
|
| Cyclophosphamide | 1 | 2022 | 3245 | 0.120 |
Why?
|
| Young Adult | 4 | 2024 | 22251 | 0.120 |
Why?
|
| Analgesics, Opioid | 1 | 2024 | 1468 | 0.110 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 2650 | 0.110 |
Why?
|
| Survival | 1 | 2014 | 183 | 0.110 |
Why?
|
| Proportional Hazards Models | 1 | 2022 | 5101 | 0.110 |
Why?
|
| Antirheumatic Agents | 1 | 2016 | 230 | 0.110 |
Why?
|
| Self Report | 1 | 2016 | 796 | 0.100 |
Why?
|
| Risk Factors | 2 | 2022 | 17888 | 0.100 |
Why?
|
| Sex Factors | 1 | 2016 | 2184 | 0.090 |
Why?
|
| Hospitalization | 2 | 2017 | 2167 | 0.090 |
Why?
|
| Biomarkers | 1 | 2022 | 5051 | 0.090 |
Why?
|
| Referral and Consultation | 1 | 2016 | 931 | 0.090 |
Why?
|
| Critical Illness | 1 | 2014 | 739 | 0.080 |
Why?
|
| Cohort Studies | 1 | 2021 | 9470 | 0.080 |
Why?
|
| United States | 2 | 2024 | 15861 | 0.080 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 901 | 0.080 |
Why?
|
| Age Factors | 1 | 2016 | 5457 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 5162 | 0.060 |
Why?
|
| Tertiary Care Centers | 2 | 2017 | 417 | 0.060 |
Why?
|
| Male | 5 | 2024 | 128315 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 6177 | 0.060 |
Why?
|
| Texas | 1 | 2014 | 6449 | 0.060 |
Why?
|
| Health Care Surveys | 1 | 2024 | 418 | 0.050 |
Why?
|
| Drug Prescriptions | 1 | 2024 | 311 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2014 | 6764 | 0.050 |
Why?
|
| Survival Rate | 1 | 2014 | 12541 | 0.050 |
Why?
|
| Autoimmune Diseases | 1 | 2024 | 436 | 0.040 |
Why?
|
| Adolescent | 2 | 2024 | 32767 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 30998 | 0.040 |
Why?
|
| Outpatients | 1 | 2016 | 463 | 0.030 |
Why?
|
| Cancer Care Facilities | 1 | 2017 | 907 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2017 | 9292 | 0.020 |
Why?
|
| Prognosis | 1 | 2016 | 22505 | 0.010 |
Why?
|